CS

Radim Nencka, Ph.D.

mail radim.nenckainvalid-email-name@invalid-email-domainuochb.cas.cz
phone +420 220 183 265
Group leader
Radim Nencka Group
Drug Design and Medicinal Chemistry

Profile

Education
1996-2001
M.Sc. in Pharmacy, at Charles University in Prague, Faculty of Pharmacy in Hradec Králové (under supervision of Prof. Manolis Stratakis at University of Crete, Greece and Miroslav Miletín, Ph.D. at Charles University).
2001-2008
Ph.D. in Organic Chemistry at Department of Organic Chemistry, Charles University, Prague; (under supervision of Dr. H. Hřebabecký at Institute of Organic Chemistry and Biochemistry of the CAS).
Appointments
2009-2010
Postdoctoral Fellow at Laboratory of Medicinal Chemistry (Prof. Serge Van Calenbergh), Faculty of Pharmaceutical Sciences, University of Ghent, Ghent, Belgium. (Synthesis of nucleotide analogues as P2Y2 receptor ligands).
2001 (5 months)
Short stay at University of Crete, Heraklion, Greece.
Since 2010
Head of the Junior Research Team, Institute of Organic Chemistry and Biochemistry of the CAS.
All publications

Latest publications

Chapter One - Computational strategies for the design of proteolysis targeting chimera degraders: Artificial intelligence enabled PROTAC design
R. Kamaraj R. Nencka P. Pávek
Annual Reports in Medicinal Chemistry Volume 63 (R. Nencka, Ed.), 1-37, Academic Press (2024)
Go to the publication arrow
Structure–activity relationship study of small-molecule inhibitor of Atg12-Atg3 protein–protein interaction
K. Škach J. Böserle G. C. Nuta P. Břehová S. Bialik N. Kozer H. Barr E. Chaloupecká A. Kimchi R. Nencka
Bioorganic and Medicinal Chemistry Letters 112: 129939 (2024)
Go to the publication arrow
Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39
E. Žilecká M. Klíma M. Štefek M. Dejmek R. Nencka E. Bouřa
Journal of Structural Biology: X 10: 100109 (2024)
Go to the publication arrow